{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:24:01Z","timestamp":1780950241692,"version":"3.54.1"},"posted":{"date-parts":[[2025,12,3]]},"group-title":"In Review","reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,16]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Solid tumors, including hepatocellular carcinoma (HCC), arises most often in cirrhotic livers, where immune exclusion and metabolic reprogramming drive extracellular acidosis (the \u201cWarburg effect\u201d) and create an immunosuppressive tumor microenvironment (TME). This study applied a non-invasive MR Spectroscopic Imaging method called Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) to quantify extracellular pH (pH\n                  <sub>e<\/sub>\n                  ) dynamics in a mouse model of cirrhosis-associated HCC. Forty-two Mdr2\u207b\/\u207b mice received chronic carbon tetrachloride (CCl\u2084), inducing cirrhosis and HCC, confirmed by contrast-enhanced MR and histology. BIRDS revealed significantly lower tumor pH\n                  <sub>e<\/sub>\n                  in untreated tumors (6.78\u2009\u00b1\u20090.3) compared with liver parenchyma (7.17\u2009\u00b1\u20090.02). Cryoablation induced tumor pH\n                  <sub>e<\/sub>\n                  normalization (7.08\u2009\u00b1\u20090.03), coinciding with downregulation of metabolic markers and increased T-cell and macrophage infiltration. These results demonstrate that BIRDS enables non-invasive monitoring of the metabolic and immunologic response to cryoablation in HCC within cirrhotic livers. Cryoablation-induced re-normalization of tumor acidity, coupled with enhanced immune activity, suggests a favorable therapeutic outcome and establishes pH\n                  <sub>e<\/sub>\n                  imaging as a tool for assessing treatment efficacy in acidic TMEs.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7879236\/v1","type":"posted-content","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T11:42:24Z","timestamp":1764762144000},"source":"Crossref","is-referenced-by-count":1,"title":["Overcoming Immune Exclusion in a Murine Model of Cirrhotic Hepatocellular Carcinoma via Cryoablation: Insights from Molecular Extracellular pH Imaging"],"prefix":"10.21203","author":[{"given":"Daniel","family":"Coman","sequence":"first","affiliation":[{"name":"Yale University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Gois","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Shewarega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Louise","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzent","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmeed","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"20204","key":"ref1","first-page":"89469","article-title":"Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999\u20132019)","volume":"13","author":"Ali H","unstructured":"Ali, H., Vikash, F., Moond, V. & Khalid, F. Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999\u20132019). World J Virol., 13, 89469 (20204).","journal-title":"World J Virol."},{"key":"ref2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyx180","article-title":"Chemotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"48","author":"Ikeda M","year":"2018","unstructured":"Ikeda, M. et al. Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Jpn. J. Clin. Oncol.48, 103\u2013114 (2018).","journal-title":"Jpn. J. Clin. Oncol"},{"key":"ref4","first-page":"64","article-title":"Current management of advanced hepatocellular carcinoma","volume":"2","author":"Abou-Alfa GK","year":"2008","unstructured":"Abou-Alfa, G. K. et al. Current management of advanced hepatocellular carcinoma. Gastrointest. Cancer Res. 2, 64\u201370 (2008).","journal-title":"Gastrointest. Cancer Res."},{"key":"ref5","first-page":"1245","volume":"379","author":"Forner A","year":"2012","unstructured":"Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245\u20131255 (2012).","journal-title":"J. Hepatocellular carcinoma. Lancet"},{"key":"ref6","first-page":"1536","article-title":"Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies","volume":"9","author":"Cheng H","year":"2019","unstructured":"Cheng, H. et al. Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies. Am. J. Cancer Res. 9, 1536\u20131545 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng AL","year":"2022","unstructured":"Cheng, A. L. et al. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J. Hepatol. 76, 862\u2013873 (2022).","journal-title":"J. Hepatol."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e204564","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau T","year":"2020","unstructured":"Yau, T. et al. Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial. JAMA Oncol. 6, e204564 (2020).","journal-title":"JAMA Oncol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"v874","DOI":"10.1093\/annonc\/mdz394.029","article-title":"CheckMate 459: a randomized, multi-centre phase III study of nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma","author":"Yau T","year":"2019","unstructured":"Yau, T. et al. CheckMate 459: a randomized, multi-centre phase III study of nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma. Ann. Oncol. 30, Suppl. 5, v874\u2013v875 (2019).","journal-title":"Ann. Oncol. 30, Suppl."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumour microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen C","year":"2023","unstructured":"Chen, C., Wang, Z., Ding, Y. & Qin, Y. Tumour microenvironment-mediated immune evasion in hepatocellular carcinoma. Front. Immunol. 14, 1133308 (2023).","journal-title":"Front. Immunol."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/BF01736087","article-title":"Versuche an \u00fcberlebendem Carcinomgewebe","volume":"3","author":"Warburg O","year":"1924","unstructured":"Warburg, O., Negelein, E. & Posener, K. Versuche an \u00fcberlebendem Carcinomgewebe. Klin. Wochenschr. 3, 1062\u20131064 (1924).","journal-title":"Klin. Wochenschr."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","article-title":"Similarities and distinctions of cancer and immune metabolism in inflammation and tumors","volume":"26","author":"Andrejeva G","year":"2017","unstructured":"Andrejeva, G. & Rathmell, J.C. Similarities and distinctions of cancer and immune metabolism in inflammation and tumors. Cell Metab. 26, 49\u201370 (2017).","journal-title":"Cell Metab."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang CH","year":"2015","unstructured":"Chang, C.H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo J","year":"2013","unstructured":"Crespo, J., Sun, H., Welling, T.H., Tian, Z. & Zou, W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 25, 214\u2013221 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"J. T cell exhaustion","volume":"12","author":"Wherry E","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat Immunol 12, 492\u2013499 (2011).","journal-title":"Nat Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.21037\/jgo.2017.06.08","article-title":"Immunomodulation in hepatocellular cancer","volume":"9","author":"Lee S","year":"2018","unstructured":"Lee, S., Loecher, M. & Iyer, R. Immunomodulation in hepatocellular cancer. J. Gastrointest. Oncol. 9, 208\u2013219 (2018).","journal-title":"J. Gastrointest. Oncol."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3389\/fimmu.2019.02283","article-title":"Cryoablation and immunotherapy: an enthralling synergy to confront the tumors","volume":"10","author":"Yakkala C","year":"2019","unstructured":"Yakkala, C., Chiang, C. L., Kandalaft, L., Denys, A. & Duran, R. Cryoablation and immunotherapy: an enthralling synergy to confront the tumors. Front. Immunol. 10, 2283 (2019).","journal-title":"Front. Immunol."},{"key":"ref18","first-page":"1","article-title":"Cryoablation combined with dual immune checkpoint blockade enhances antitumor efficacy in hepatocellular carcinoma model mice","volume":"41","author":"Gu J","year":"2024","unstructured":"Gu, J., Yu, Z., Tang, X., Chen, W., Deng, X. & Zhu, X. Cryoablation combined with dual immune checkpoint blockade enhances antitumor efficacy in hepatocellular carcinoma model mice. Int. J. Hyperthermia 41, 1 (2024).","journal-title":"Int. J. Hyperthermia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1094009","DOI":"10.3389\/fimmu.2023.1094009","article-title":"Progress in the cryoablation and cryoimmunotherapy for tumor","volume":"14","author":"Chen Z","year":"2023","unstructured":"Chen, Z., Meng, L., Zhang, J. & Zhang, X. Progress in the cryoablation and cryoimmunotherapy for tumor. Front. Immunol. 14, 1094009 (2023).","journal-title":"Front. Immunol."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cryobiol.2013.11.001","article-title":"Mechanisms of cryoablation: clinical consequences on malignant tumors","volume":"68","author":"Baust JG","year":"2014","unstructured":"Baust, J.G., Gage, A.A., Bjerklund Johansen, T.E. & Baust, J.M. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology 68, 1\u201311 (2014).","journal-title":"Cryobiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"18229","DOI":"10.1038\/s41598-022-22279-w","article-title":"Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model","volume":"12","author":"Mauda-Havakuk M","year":"2022","unstructured":"Mauda-Havakuk, M., Hawken, N.M., Owen, J.W. et al. Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model. Sci. Rep. 12, 18229 (2022).","journal-title":"Sci. Rep."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet JM","year":"2021","unstructured":"Llovet, J.M., De Baere, T., Kulik, L., Haber, P.K., Greten, T.F., Meyer, T. & Lencioni, R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 293\u2013313 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"81967","DOI":"10.18632\/oncotarget.17804","article-title":"Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer","volume":"8","author":"Lin M","year":"2017","unstructured":"Lin, M., Liang, S., Wang, X., Liang, Y., Zhang, M., Chen, J., Niu, L. & Xu, K. Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer. Oncotarget 8, 81967\u201381977 (2017).","journal-title":"Oncotarget"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4251\/wjgo.v15.i1.1","article-title":"Combining local regional therapy and systemic therapy: expected changes in the treatment landscape of recurrent hepatocellular carcinoma","volume":"15","author":"Liang J","year":"2023","unstructured":"Liang, J., Bai, Y., Ha, F.S., Luo, Y., Deng, H.T. & Gao, Y.T. Combining local regional therapy and systemic therapy: expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World J. Gastrointest. Oncol. 15, 1\u201318 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/nbm.2995","article-title":"In vivo three-dimensional molecular imaging with Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) at high spatiotemporal resolution","volume":"26","author":"Coman D","year":"2013","unstructured":"Coman, D., de Graaf, R.A., Rothman, D.L., Hyder, F. In vivo three-dimensional molecular imaging with Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) at high spatiotemporal resolution. NMR Biomed 26, 1589\u20131595 (2013).","journal-title":"NMR Biomed"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/nbm.1461","article-title":"Brain temperature by Biosensor Imaging of Redundant Deviation in Shifts (BIRDS): comparison between TmDOTP5- and TmDOTMA","volume":"23","author":"Coman D","year":"2010","unstructured":"Coman, D., Trubel, H.K., Hyder, F. Brain temperature by Biosensor Imaging of Redundant Deviation in Shifts (BIRDS): comparison between TmDOTP5- and TmDOTMA. NMR Biomed 23, 277\u2013285 (2010).","journal-title":"NMR Biomed"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/nbm.3466","article-title":"Imaging the intratumoral\u2013peritumoral extracellular pH gradient of gliomas","volume":"29","author":"Coman D","year":"2016","unstructured":"Coman, D., Huang, Y., Rao, J.U., De Feyter, H.M., Rothman, D.L., Juchem, C. & Hyder, F. Imaging the intratumoral\u2013peritumoral extracellular pH gradient of gliomas. NMR Biomed. 29, 309\u2013319 (2016).","journal-title":"NMR Biomed."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/nbm.3578","article-title":"Towards longitudinal mapping of extracellular pH in gliomas","volume":"29","author":"Huang Y","year":"2016","unstructured":"Huang, Y., Coman, D., Herman, P., Rao, J.U., Maritim, S. & Hyder, F. Towards longitudinal mapping of extracellular pH in gliomas. NMR Biomed. 29, 1364\u20131372 (2016).","journal-title":"NMR Biomed."},{"key":"ref29","first-page":"3849373","article-title":"Mapping extracellular pH of gliomas in presence of superparamagnetic nanoparticles","author":"Maritim S","year":"2017","unstructured":"Maritim, S., Coman, D., Huang, Y. & Rao, J.U. Mapping extracellular pH of gliomas in presence of superparamagnetic nanoparticles. Contrast Media Mol Imaging, 3849373 (2017).","journal-title":"Contrast Media Mol Imaging"},{"key":"ref30","first-page":"7863","article-title":"Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH","volume":"7","author":"Rao JU","year":"2017","unstructured":"Rao, J.U., Coman, D., Walsh, J.J., Ali, M.M. & Huang, Y. Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH. Sci Rep. 7, 7863 (2017).","journal-title":"Sci Rep."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e5102","DOI":"10.1002\/nbm.5102","article-title":"Transmembrane pH gradient imaging in rodent glioma models","volume":"37","author":"Mishra SK","year":"2024","unstructured":"Mishra, S.K., Santana, J.G., Mihailovic, J., Hyder, F. & Coman, D. Transmembrane pH gradient imaging in rodent glioma models. NMR Biomed.,37, e5102 (2024).","journal-title":"NMR Biomed."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.2020200373","article-title":"Molecular MRI of the immuno-metabolic interplay in a rabbit liver tumor model: a biomarker for resistance mechanisms in tumor-targeted therapy?","volume":"296","author":"Savic LJ","year":"2020","unstructured":"Savic, L.J. et al. Molecular MRI of the immuno-metabolic interplay in a rabbit liver tumor model: a biomarker for resistance mechanisms in tumor-targeted therapy? Radiology 296, 575\u2013583 (2020).","journal-title":"Radiology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jvir.2020.04.010","article-title":"Idarubicin-loaded ONCOZENE drug-eluting bead chemoembolization in a rabbit liver tumor model: investigating safety, therapeutic efficacy, and effects on tumor acidosis","volume":"31","author":"Borde T","year":"2020","unstructured":"Borde, T., Gaupp, F.L., Geschwind, J.F. & Savic, L.J. Idarubicin-loaded ONCOZENE drug-eluting bead chemoembolization in a rabbit liver tumor model: investigating safety, therapeutic efficacy, and effects on tumor acidosis. J Vasc Interv Radiol., 31, 1313\u20131322.e2 (2020).","journal-title":"J Vasc Interv Radiol."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1746-1596-9-S1-S7","article-title":"Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis","volume":"9","author":"Garc\u00eda-Rojo M","year":"2014","unstructured":"Garc\u00eda-Rojo, M. et al. Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis. Diagn. Pathol. 9, S7 (2014).","journal-title":"Diagn. Pathol."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","article-title":"Optimized mouse models for liver fibrosis","volume":"1559","author":"Kim YO","year":"2017","unstructured":"Kim, Y. O., Popov, Y. & Schuppan, D. Optimized mouse models for liver fibrosis. Methods Mol. Biol. 1559, 279\u2013296 (2017).","journal-title":"Methods Mol. Biol."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: upstream and downstream of cancer metabolism","volume":"20","author":"Semenza GL","year":"2010","unstructured":"Semenza, G. L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 20, 51\u201356 (2010).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.3390\/ijms160511055","article-title":"Molecular connections between cancer cell metabolism and the tumor microenvironment","volume":"16","author":"Justus CR","year":"2015","unstructured":"Justus, C. R., Sanderlin, E. J. & Yang, L. V. Molecular connections between cancer cell metabolism and the tumor microenvironment. Int. J. Mol. Sci. 16, 11055\u201311086 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"ref38","first-page":"5762086","article-title":"Resistance to therapy in solid tumors: reprogramming of cellular metabolism and drug resistance","author":"Condello M","year":"2018","unstructured":"Condello, M., Mancini, G. & Meschini, S. Resistance to therapy in solid tumors: reprogramming of cellular metabolism and drug resistance. Biomed. Res. Int., 5762086 (2018).","journal-title":"Biomed. Res. Int."},{"key":"ref39","article-title":"Cryoablation augments tumor antigen presentation and primes intratumoral CD8\u207a T cell responses in murine models","author":"Qian Y","year":"2024","unstructured":"Qian, Y. et al. Cryoablation augments tumor antigen presentation and primes intratumoral CD8\u207a T cell responses in murine models. Cancer Immunol. Res. (2024).","journal-title":"Cancer Immunol. Res."},{"key":"ref40","article-title":"Cryoablation remodels the tumor microenvironment and enhances immune checkpoint blockade efficacy","author":"Gu L","year":"2024","unstructured":"Gu, L. et al. Cryoablation remodels the tumor microenvironment and enhances immune checkpoint blockade efficacy. Front. Oncol. (2024).","journal-title":"Front. Oncol"},{"key":"ref41","volume-title":"Molecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinoma","author":"Santana JG","year":"2025","unstructured":"Santana, J. G. Shewarega, A., Nam, D. et al. Molecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinoma. J. Hepatol. Reports (in press, 2025)"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"e232365","DOI":"10.1148\/radiol.232365","article-title":"Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8\u2009+\u2009T-Cell Infiltration in Murine Hepatocellular Carcinoma","volume":"310","author":"Shewarega A","year":"2024","unstructured":"Shewarega A, Santana JG, Nam D, et al. Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8\u2009+\u2009T-Cell Infiltration in Murine Hepatocellular Carcinoma. Radiology. 310(2):e232365 (2024).","journal-title":"Radiology."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response","volume":"7","author":"Keenan BP","year":"2019","unstructured":"Keenan, B. P., Fong, L. & Kelley, R. K. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J. Immunother. Cancer 7, 267 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review","volume":"22","author":"Oura K","year":"2021","unstructured":"Oura, K. et al. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int. J. Mol. Sci. 22, 5801 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"ref45","first-page":"1700","article-title":"Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma","volume":"31","author":"Liu X","year":"2023","unstructured":"Liu, X., Zhou, J., Wu, H., Chen, S., Zhang, L. & Tang, W. Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Mol. Ther. 31, 1700\u20131716 (2023).","journal-title":"Mol. Ther."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne R","year":"2023","unstructured":"Donne, R. & Lujambio, A. The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology 77, 1773\u20131786 (2023).","journal-title":"Hepatology"},{"key":"ref47","first-page":"397","article-title":"Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival","volume":"74","author":"Llovet JM","year":"2021","unstructured":"Llovet, J. M., Montal, R. & Villanueva, A. Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival. J. Hepatol. 74, 397\u2013398 (2021).","journal-title":"J. Hepatol."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7879236\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7879236\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T11:42:32Z","timestamp":1764762152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7879236\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":47,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7879236\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,12,3]]},"subtype":"preprint"}}